We sell in-depth short-selling reports for any company ₿ 1 BTC.
Contact us today.
Short Interest Update USOVID

OVID Short Interest Plummets Ahead of Q3 Earnings

OVID is seeing a rapid unwind of short positions as the stock rallies, with short interest dropping 33% over the past month.

Powered by NegativePublicRelations.com
By The Forensic Ledger Desk November 10, 20261 min read
Company
Ovid Therapeutics Inc.
Borrow Fee
0.70%
Short % Float
23.2%
Days to Cover
0

Rapid Short Unwind

OVID enters its November 13 earnings print on the back of a sharp short squeeze in the lending market. Short interest as a percentage of free float currently stands at 23.2%, down significantly from the 26 million shares shorted in late September to approximately 16.5 million today. This substantial cover coincides with a 19% weekly gain in the stock price.

Borrow Market Conditions

Borrow conditions have loosened considerably. Availability has expanded to 227%, a stark contrast to the 52-week tightest level of 43%. The cost to borrow remains negligible at 0.70%, suggesting that the recent reduction in short positions is driven by a reassessment of clinical risk rather than a forced squeeze due to borrow scarcity.

Source

Signal data sourced from Ortex. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.

#Short Interest#Earnings#OVID

Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.

Commission a Report · The Forensic Ledger Desk

Forensic Research & Investigations

We conduct deep investigative research into publicly traded companies — deploying forensic accountants, field investigators, and industry experts to uncover business fraud (overstated revenues), accounting fraud (inflated profits), or severe fundamental business flaws.

Commission us to compose a short-seller research report on a company you target. Every dossier is built to evidentiary standards — sourced, falsifiable, and ready to move markets. Costs: ₿ 1 BTC

Commission a Report
Business Fraud

Overstated revenues, fake channels, pulled-forward demand.

Accounting Fraud

Inflated profits, aggressive recognition, hidden liabilities.

Fundamental Flaws

Structural business defects the market has mispriced.

The Negative PR Blog

The internet's leading source on negative PR campaigns, smear campaigns, bad press, and reputation warfare — real, recent events documented and dissected by our reporters, with expert analysis of how we'd respond.

Read the Blog
Contact Us on Telegram